Correlation between Oral Thiamine as an Opioid Adjuvant and Cathecol-O-Methyltransferase Enzyme Levels in Cervical Cancer Patients

Nur Surya Wirawan Syamsu; Ferdinan  Bastian Sirait; Muh. Ramli   Ahmad; Syafruddin  Gaus; Alamsyah Ambo Ala  Husain; Madonna D.  Datu; Andi Alfian  Zainuddin

doi:10.3889/oamjms.2023.11012

Authors

Nur Surya Wirawan Syamsu Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia https://orcid.org/0000-0001-9378-733X
Ferdinan Bastian Sirait Department of Anesthesiology https://orcid.org/0000-0001-9679-2214
Muh. Ramli Ahmad Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Syafruddin Gaus Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Alamsyah Ambo Ala Husain Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Madonna D. Datu Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Andi Alfian Zainuddin Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2023.11012

Keywords:

Cancer pain, Cervical cancer, Thiamine, COMT, NRS

Abstract

BACKGROUND: The high prevalence of cancer pain shows that a lot of the patients are undertreatment. Vitamin B is one of the additional alternative substances studied in cancer pain management. Thiamine is believed to modulate pain mechanisms in lowering the Cathecol-O-Methyltransferase (COMT) enzyme level.

AIM: The aim of the study was to assess the correlation between Oral Thiamine as an Opioid Adjuvant and COMT Enzyme Levels in Cervical Cancer Patients

METHODS: This research is a quasi-experimental study with a pre-test and post-test control group design. Patients in this study were 32 cervical cancer patients who experienced cancer pain, divided into two groups (treatment and control groups). The treatment group received morphine plus thiamine 500 mg/8 h/oral, and the control group received morphine alone. Measurement and evaluation of pain scores were carried out after 72 h of thiamine administration and blood collection was carried out again 4 h after the last thiamine administration to check thiamine levels and COMT. Then, data collection and analysis is being evaluated.

RESULTS: From 32 cervical cancer patients studied, there were differences in changes in numeric rating scale (NRS) levels and COMT levels in the thiamine treatment group.

CONCLUSIONS: The administration of thiamine can reduce COMT enzyme levels and clinically reduce NRS in cervical cancer patients. If it confirmed by other findings, thiamine might be considered for its use in the treatment of cancer pain.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492 PMid:30207593 DOI: https://doi.org/10.3322/caac.21492

Bruni L, Barrionuevo-Rosas L, Albero G, Albero G, Serrano B, Mena M, Gómez D, et al. Human Papillomavirus and Related Diseases in Indonesia: Summary Report, ICO Information Centre on HPV and Cancer (HPV Information Centre); 2016. Available from: https://www.hpvcentre.net/statistics/reports [Last accessed on 2021 Dec 23].

Ministry of Health of the Republic of Indonesia. World Cancer Day 2019. Indonesia: Ministry of Health of the Republic of Indonesia; 2019. Available from: https://www.depkes.go.id [Last accessed on 2021 Dec 23].

Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152(1):87-93. https://doi.org/10.1016/j.ygyno.2018.10.026 PMid:30389105 DOI: https://doi.org/10.1016/j.ygyno.2018.10.026

Van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070- 90.e9. https://doi.org/10.1016/j.jpainsymman.2015.12.340 PMid:27112310 DOI: https://doi.org/10.1016/j.jpainsymman.2015.12.340

Javier FO, Irawan C, Mansor MB, Sriraj W, Tan KH, Thinh DH. Cancer pain management insights and reality in Southeast Asia: Expert perspectives from six countries. J Glob Oncol. 2016;2(4):235-43. https://doi.org/10.1200/JGO.2015.001859 PMid:28717706 DOI: https://doi.org/10.1200/JGO.2015.001859

Braga AV, Costa SO, Rodrigues FF, Melo IS, Morais MI, Coelho MM, et al. Thiamine, riboflavin, and nicotinamide inhibit paclitaxel-induced allodynia by reducing TNF-α and CXCL-1 in dorsal root ganglia and thalamus and activating ATP-sensitive potassium channels. Inflammopharmacology. 2020;28(1):201-13. https://doi.org/10.1007/s10787-019-00625-1 PMid:31388880 DOI: https://doi.org/10.1007/s10787-019-00625-1

Nasution AH, Lelo A, Effendy E, Wijaya DW. The effect of thiamine administration on catechol-o-methyltransferase (COMT) enzyme level and Amsterdam preoperative anxiety and information scale (APAIS) value in patients with preoperative anxiety. J Drug Alcohol Res. 2019:8(2):1-6. https://doi.org/10.4303/jdar/236086

Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2-and beta3- adrenergic receptors. Pain. 2007;128(3):199-208. https://doi.org/10.1016/j.pain.2006.09.022 PMid:17084978 DOI: https://doi.org/10.1016/j.pain.2006.09.022

Isenberg-Grzeda E, Shen MJ, Alici Y, Wills J, Nelson C, Breitbart W. High rate of thiamine deficiency among inpatients with cancer referred for psychiatric consultation: Results of a single site prevalence study. Psychooncology. 2017;26(9):1384-9. https://doi.org/10.1002/pon.4155 PMid:27228202 DOI: https://doi.org/10.1002/pon.4155

Osiezagha K, Ali S, Freeman C, Barker NC, Jabeen S, Maitra S, et al. Thiamine deficiency and delirium. Innov Clin Neurosci. 2013;10(4):26-32. PMid:23696956

Liu X, Montissol S, Uber A, Ganley S, Grossestreuer AV, Berg K, et al. The effects of thiamine on breast cancer cells. Molecules. 2018;23(6):1464. https://doi.org/10.3390/molecules23061464 DOI: https://doi.org/10.3390/molecules23061464

Rietz A, Spiers J. The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases. Br J Pharmacol. 2012;166(4):1225-43. https://doi.org/10.1111/j.1476-5381.2012.01917.x PMid:22364165 DOI: https://doi.org/10.1111/j.1476-5381.2012.01917.x

Wu W, Wu Q, Hong X, Xiong G, Xiao Y, Zhou J, et al. Catechol- O-methyltransferase inhibits colorectal cancer cell proliferation and invasion. Arch Med Res. 2015;46(1):17-23. https://doi.org/10.1016/j.arcmed.2014.12.004 PMid:25532943 DOI: https://doi.org/10.1016/j.arcmed.2014.12.004

Antonio C, Massimo T, Gianpaolo Z, Immacolata PM, Erika T. Oral high-dose thiamine improves the symptoms of chronic cluster headache. Case Rep Neurol Med. 2018;2018:3901619. https://doi.org/10.1155/2018/3901619 PMid:29850313 DOI: https://doi.org/10.1155/2018/3901619

Lu’o’ng KV, Nguyễn LT. The role of thiamine in cancer: Possible genetic and cellular signaling mechanisms. Cancer Genomics Proteomics. 2013;10(4):169-85. PMid:23893925

Cascante M, Centelles JJ, Veech RL, Lee WN, Boros LG. Role of thiamin (Vitamin B-1) and transketolase in tumor cell proliferation. Nutr Cancer. 2000;36(2):150-4. https://doi.org/10.1207/S15327914nc3602_2 PMid:10890024 DOI: https://doi.org/10.1207/S15327914NC3602_2

Fernandes LM, Bezerra FR, Monteiro MC, Silva ML, de Oliveira FR, Lima RR, et al. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: How poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. Eur J Clin Nutr. 2017;71(5):580-6. https://doi.org/10.1038/ejcn.2016.267 PMid:28225048 DOI: https://doi.org/10.1038/ejcn.2016.267

Hamdi T, Ganie RA, Lelo A, Wijaya DW, Nasution IP, Munir D, et al. The Influence of oral thiamine as an adjuvant to morphine on catechol-o-methyltransferase (COMT) in pain associated with breast cancer. J Drug Alcohol Res. 2021:10(6):1-6. https://doi.org/10.4303/jdar/236131

Kambur O, Männistö PT. Catechol-O-methyltransferase and pain. Int Rev Neurobiol. 2010;95:227-79. https://doi.org/10.1016/B978-0-12-381326-8.00010-7 PMid:21095465 DOI: https://doi.org/10.1016/B978-0-12-381326-8.00010-7

Sadhasivam S, Chidambaran V, Olbrecht VA, Esslinger HR, Zhang K, Zhang X, et al. Genetics of pain perception, COMT and postoperative pain management in children. Pharmacogenomics. 2014;15(3):277-84. https://doi.org/10.2217/pgs.13.248 PMid:24533707 DOI: https://doi.org/10.2217/pgs.13.248

Matsuoka H, Makimura C, Koyama A, Fujita Y, Tsurutani J, Sakai K, et al. Prospective replication study implicates the catechol-O-methyltransferase val158met polymorphism as a biomarker for the response to morphine in patients with cancer. Biomed Rep. 2017;7(4):380-4. https://doi.org/10.3892/br.2017.963 PMid:28928973 DOI: https://doi.org/10.3892/br.2017.963